| A guide to the composition and functions of the extracellular matrix NK Karamanos, AD Theocharis, Z Piperigkou, D Manou, A Passi, ... The FEBS journal 288 (24), 6850-6912, 2021 | 652 | 2021 |
| The extracellular matrix as a multitasking player in disease AD Theocharis, D Manou, NK Karamanos The FEBS journal 286 (15), 2830-2869, 2019 | 432 | 2019 |
| The complex interplay between extracellular matrix and cells in tissues D Manou, I Caon, P Bouris, IE Triantaphyllidou, C Giaroni, A Passi, ... The extracellular matrix: Methods and protocols, 1-20, 2019 | 131 | 2019 |
| Strategies to target matrix metalloproteinases as therapeutic approach in cancer Z Piperigkou, D Manou, K Karamanou, AD Theocharis Proteases and cancer: methods and protocols, 325-348, 2018 | 72 | 2018 |
| Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling P Bouris, D Manou, A Sopaki-Valalaki, A Kolokotroni, A Moustakas, ... Matrix Biology 74, 35-51, 2018 | 64 | 2018 |
| Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling D Manou, NK Karamanos, AD Theocharis Seminars in Cancer Biology 62, 108-115, 2020 | 44 | 2020 |
| Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential D Manou, P Bouris, D Kletsas, M Götte, B Greve, A Moustakas, ... Matrix Biology Plus 6, 100033, 2020 | 19 | 2020 |
| Proteoglycans determine the dynamic landscape of EMT and cancer cell stemness Z Karagiorgou, PN Fountas, D Manou, E Knutsen, AD Theocharis Cancers 14 (21), 5328, 2022 | 15 | 2022 |
| Synthesis and antiproliferative activity of novel dehydroabietic acid-chalcone hybrids S Grigoropoulou, D Manou, AI Antoniou, A Tsirogianni, C Siciliano, ... Molecules 27 (11), 3623, 2022 | 10 | 2022 |
| Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway KE Siatis, E Giannopoulou, D Manou, P Sarantis, MV Karamouzis, ... American Journal of Physiology-Cell Physiology 325 (3), C708-C720, 2023 | 8 | 2023 |
| The Expression of Serglycin Is Required for Active Transforming Growth Factor β Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal … D Manou, MA Golfinopoulou, SND Alharbi, HA Alghamdi, FM Alzahrani, ... Biomolecules 14 (4), 461, 2024 | 1 | 2024 |
| Simvastatin affects EMT and stemness phenotype of triple negative breast cancer cells VD Fytsilis, D Manou, AD Theocharis, SS Skandalis, D Vynios | 1 | 2022 |
| Expression of CD44 is associated with aggressiveness in seminomas VT Labropoulou, D Manou, P Ravazoula, FM Alzahrani, HP Kalofonos, ... Molecular Biology Reports 51 (1), 693, 2024 | | 2024 |
| New Esters of Ferrediol and Sideritriol in Sideritis clandestina subsp. peloponnesiaca: Characterization and Antiproliferative Activity VD Dimaki, E Stamopoulou, D Manou, AD Theocharis, MA Fousteris, ... ACS omega 9 (41), 42253-42260, 2024 | | 2024 |
| TMIC-73. UNRAVELING THE ALTERED EXTRACELLULAR MATRIX LANDSCAPE IN GLIOBLASTOMA AFTER RADIATION TREATMENT D Manou, R Rosberg, A Pietras Neuro-Oncology 25 (Suppl 5), v294, 2023 | | 2023 |
| The microRNA-Extracellular Matrix Interplay in Breast Cancer Z Piperigkou, D Manou, D Bainantzou, V Zolota, Ε Papakonstantinou, ... The Extracellular Matrix and the Tumor Microenvironment, 421-436, 2022 | | 2022 |
